HealthEquity, Inc. (HQY)

HealthEquity, Inc. (HQY) is a healthcare company (health information services) based in the United States. The share price is $102.30, down 2.18% on the day, which values the company at $8.46B. Price as of 17 Nov 2026, 19:13 UTC, from Yahoo Finance.

Key facts

Share price
$102.30−2.18% today
Market value
$8.46B
P/E ratio
36.9×last 12 months
Forward P/E
18.5×
Funk Score
78/100
Against its own history
Well below its usual priceusual price $160.11
200-week average
$83.4723% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

HealthEquity, Inc. in more detail

HQY trades at 36.9× its last twelve months' earnings, 18.5× next year's expected earnings, 6.2× sales. Measured against its own history, the price is 36% below what its usual multiples would imply ($160.11) — well below its usual price. It sits 23% above its 200-week average of $83.47.

Over the last five fiscal years HealthEquity, Inc. has compounded revenue 12.4% a year, earnings per share 83.0% a year, free cash flow 19.4% a year. Its Funk Score is 78 out of 100 (financial strength 6.6, profitability 7.9, growth 8.7, value 8.1, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score.

1 of the superinvestors tracked here hold HQY, including Ron Baron (0.1% of the portfolio).

Superinvestors holding HQY

1 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:HQY vs TXG (HealthEquity, Inc. vs 10x Genomics)HQY vs CORT (HealthEquity, Inc. vs Corcept Therapeutics)HQY vs KRYS (HealthEquity, Inc. vs Krystal Biotech)HQY vs PTGX (HealthEquity, Inc. vs Protagonist Therapeutics)HQY vs TWST (HealthEquity, Inc. vs Twist Bioscience)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

HealthEquity, Inc. (HQY): questions and answers

What is HQY's P/E ratio?

HealthEquity, Inc. trades at 36.9× its last twelve months' earnings and 18.5× next year's expected earnings. At its fiscal year-ends over the past 9 years the P/E ranged from 34.8× to 118.1×, with a median of 98.9×.

What is HQY's PEG ratio?

HealthEquity, Inc.'s PEG ratio is 1.27 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is HealthEquity, Inc.'s market cap?

HealthEquity, Inc. is valued at $8.46B at a share price of $102.30.

Is HQY overvalued or undervalued?

Against its own history, HQY is well below its usual price: the price is 36% below the $160.11 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is HQY above its 200-week moving average?

Yes. HQY is 22.6% above its 200-week average of $83.47. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is HealthEquity, Inc. growing?

Over the last five fiscal years HealthEquity, Inc.'s revenue grew 12.4% a year and its earnings per share 83.0% a year; over ten years revenue grew 26.3% a year.

Cite this page

Funkfolio, “HealthEquity, Inc. (HQY) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/HQY

Underlying data: Yahoo Finance; company filings with the SEC.